ESMO Preceptorship on Head and Neck Cancer 2019: Hong Kong SAR, China
![ESMO Preceptorship on Head and Neck Cancer Hong Kong 2019 banner](/var/esmo/storage/images/media/esmo/meetings/2019/preceptorships-2019/esmo-preceptorship-on-head-and-neck-cancer-hong-kong-2019-banner/3204064-2-eng-GB/esmo-preceptorship-on-head-and-neck-cancer-hong-kong-2019-banner.jpg)
- Start date
- 13 Apr 2019
- End date
- 14 Apr 2019
- Location
- Hong Kong SAR, China
Learning objectives
- To understand epidemiology, aetiology, and molecular biology of nasopharyngeal cancer and squamous cell carcinoma of the head and neck
- To understand multidisciplinary management and treatment of head and neck cancer
- To learn about advances in the treatment and novel targets in head and neck cancer
Accreditation
The programme of this event will be accredited with 10 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs
- Anthony T. C. Chan, Hong Kong
- Jean-Pascal Machiels, Belgium